drugset / Trial / NCT07167797

Evaluation of the Role of Vitamin D in Reducing the Severity and Duration of Rotavirus Infection in Iraqi Children

NCT07167797

Completed 60 enrolled University of Baghdad
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to evaluate the effect of vitamin D supplementation on the clinical outcomes including duration and severity of rotavirus-induced gastroenteritis in children that will be admitted to the hospital. And to evaluate the anti-inflammatory effect of vitamin D on the pediatrics with rotavirus gastroenteritis by measuring inflammatory markers such as C-reactive protein (CRP), neutrophil to lymphocyte ratio (NLR), platelet to lymphocytes ratio (PLR), lymphocytes to monocytes ratio (LMR) and mean platelet volume MPV.

Timeline

Start
2025-01-01
Primary completion
2025-05-01
Completion
2025-12-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 100000 iu Oral
Subject Cholecalciferol Other / unclassified 300000 iu Oral
Comparator Acetaminophen Small molecule
Comparator sodium chloride Unknown

Indications